|
|
The Role of CHAF1B in Maintaining Malignant Leukemia Stem Cells |
| 5R00CA230314-04 |
|
NCI |
2022 |
|
|
MR-Guided Precision Conformal Ablation Therapy for Brain Tumors |
| 5R01CA166379-10 |
|
NCI |
2022 |
|
|
Novel Path to Chronic Sensorimotor Dysfunction and Treatment for Chemotherapy |
| 5R01CA221363-05 |
|
NCI |
2022 |
|
|
Development of A HTLV-1 Vaccine |
| 5R01CA252049-02 |
|
NCI |
2022 |
|
|
CCL2 and CCR2 as metastatic drivers and therapeutic targets in medulloblastoma |
| 5R01CA255369-02 |
|
NCI |
2022 |
|
|
Investigating the IL-1R Pathway in Anaplastic Large Cell Lymphoma for Targeted Therapy |
| 5R01CA259188-02 |
|
NCI |
2022 |
|
|
Image-guided combination therapies for radiotherapy-induced neurocognitive impairment in pediatric brain tumor survivors |
| 5R01CA262887-02 |
|
NCI |
2022 |
|
|
Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system |
| 5R01CA263806-02 |
|
NCI |
2022 |
|
|
Identifying the mechanisms of leukemia progression |
| 5R35CA253096-02 |
|
NCI |
2022 |
|
|
Developmental regulation of apoptosis as a modifiable driver of radiotherapy-induced neurocognitive impairment in pediatric patients |
| 5R37CA248565-03 |
|
NCI |
2022 |